Mallinckrodt Pharmaceuticals, based in Staines-upon-Thames, England, with its U.S. headquarters in St. Louis, Missouri, produces specialty pharmaceutical products, including generic drugs and imaging agents.

Wikipedia

Mallinckrodt Pharmaceuticals

Category: Content
Type: Blog Article

Generated 6 days ago

New blog articles detected

  • Mallinckrodt Supports Patient Safety Awareness Week

    Mallinckrodt Pharmaceuticals is dedicated to providing safe and effective medications and therapies for the treatment of patients as well as safety within the workplace, and the company is proud to serve as the exclusive sponsor […] The post Mallinckrodt Supports Patient Safety Awareness Week appeared first on Mallinckrodt Pharmaceuticals Blog.

Mallinckrodt Pharmaceuticals

Category: Content
Type: Blog Article

Generated 6 days ago

New blog articles detected

  • Mallinckrodt named as finalist for St. Louis Arcus Award Achievement in Public Policy

    The best and brightest of the St. Louis business community gathered on February 23 for the St. Louis Chamber’s 4th annual Arcus Awards. Mallinckrodt was recognized for its efforts as a leader in the fight […] The post Mallinckrodt named as finalist for St. Louis Arcus Award Achievement in Public Policy appeared first on Mallinckrodt Pharmaceuticals Blog.

Mallinckrodt Pharmaceuticals

Category: Content
Type: Blog Article

Generated 6 days ago

New blog articles detected

Mallinckrodt Pharmaceuticals

Category: Content
Type: Blog Article

Generated 3 weeks ago

New blog articles detected

  • Rare Disease Day: Patient Advocates As Architects

    This is a guest post by Nicole Boice, Founder & CEO, Global Genes. Architects?  Yes Architects. The roll of the patient/patient advocate is rapidly evolving when it comes to their engagement in rare disease.  Patients/advocates […] The post Rare Disease Day: Patient Advocates As Architects appeared first on Mallinckrodt Pharmaceuticals Blog.

  • World RARE Disease Day Observed on Feb. 28, 2017

    One in 10 Americans is affected by a rare disease – that is 30 million people in the United States, and 350 million people globally. More than 7,000 distinct rare diseases exist today, and approximately […] The post World RARE Disease Day Observed on Feb. 28, 2017 appeared first on Mallinckrodt Pharmaceuticals Blog.

  • INFOGRAPHIC: What is a Rare Disease?

    Having a rare disease is actually not so rare. Check out out this infographic for some surprising facts and figures about rare diseases in the United States.                  […] The post INFOGRAPHIC: What is a Rare Disease? appeared first on Mallinckrodt Pharmaceuticals Blog.

Mallinckrodt Pharmaceuticals

Category: Content
Type: Blog Article

Generated 4 weeks ago

New blog articles detected

  • Mallinckrodt Supports Hand to Hold’s First Podcast for Parents of Preemies

    Support from Mallinckrodt Pharmaceuticals is helping make possible NICU Now, a free audio support series for parents of premature babies that covers such topics as guilt, grief, anxiety, bonding with a sick or medically fragile […] The post Mallinckrodt Supports Hand to Hold’s First Podcast for Parents of Preemies appeared first on Mallinckrodt Pharmaceuticals Blog.

Mallinckrodt Pharmaceuticals

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected

  • Institutional Investor Magazine Names Mallinckrodt an America’s Most Honored Company

    Mallinckrodt Pharmaceuticals has earned the designation as one of America’s Most Honored Companies in Institutional Investor magazine’s 2017 All-America Executive Team, which identifies America’s best Chief Executive Officers, Chief Financial Officers, Investor Relations (IR) Officers […] The post Institutional Investor Magazine Names Mallinckrodt an America’s Most Honored Company appeared first o...

Mallinckrodt Pharmaceuticals

Category: Content
Type: Blog Article

Generated 1 month ago

New blog articles detected

  • Mallinckrodt’s Inclusion and Diversity Efforts Earn National Recognition

    Mallinckrodt strives to make inclusion and diversity an integral part of its culture. This year, these efforts received national recognition. Mallinckrodt’s Inclusion and Diversity (I&D) Council ranked sixth on the list of top U.S. 25 […] The post Mallinckrodt’s Inclusion and Diversity Efforts Earn National Recognition appeared first on Mallinckrodt Pharmaceuticals Blog.

  • NPR Connecticut Segment Features Discussion of Opioid-Sparing Techniques Following Surgery

    New approaches to treating pain after surgery, including opioid-sparing techniques hospitals are using to help prevent risk of opioid addiction were featured on WNPR Connecticut, a National Public Radio (NPR) station, in an Aug. 22, […] The post NPR Connecticut Segment Features Discussion of Opioid-Sparing Techniques Following Surgery appeared first on Mallinckrodt Pharmaceuticals Blog.

  • Mallinckrodt Named a “Best Place to Work for LGBT Equality” on Human Rights Campaign Foundation’s 2017 Corporate Equality Index

    Mallinckrodt has earned top honors on the 2017 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to lesbian, gay, bisexual and transgender (LGBT) workplace equality. The CEI […] The post Mallinckrodt Named a “Best Place to Work for LGBT Equality” on Human Rights Campaign Foundation’s 2017 Corporate Equality Index appeared first on...

  • Mallinckrodt’s Dr. David Keenan Honored by the Dublin-Area Chamber of Commerce

    In November, Dr. David Keenan, Vice President of Global External Supply and Managing Director of Mallinckrodt Pharmaceutical Ireland, received the prestigious JC Savage Business Person of the Year Excellence Award from the Fingal Dublin Chamber. […] The post Mallinckrodt’s Dr. David Keenan Honored by the Dublin-Area Chamber of Commerce appeared first on Mallinckrodt Pharmaceuticals Blog.

  • Mallinckrodt Announces New Global Corporate Headquarters in UK

    Mallinckrodt has announced plans to establish its new Global Corporate Headquarters in Staines-upon-Thames, outside of London. The announcement was made during a luncheon attended by Mallinckrodt employees, along with city and county council members, representatives […] The post Mallinckrodt Announces New Global Corporate Headquarters in UK appeared first on Mallinckrodt Pharmaceuticals Blog.

  • Mallinckrodt’s JoAnna Schooler honored with 2016 Business Performer Award

    On November 17, the St. Louis American Foundation recognized JoAnna Schooler, Mallinckrodt’s Senior Director of Internal Communications and Community Relations for her leadership in business, presenting her with the 2016 Business Performer Award. A host […] The post Mallinckrodt’s JoAnna Schooler honored with 2016 Business Performer Award appeared first on Mallinckrodt Pharmaceuticals Blog.

  • Mallinckrodt’s Raleigh Plant Marks 50th Anniversary

    Mallinckrodt’s Raleigh, N.C., plant – home to production of the company’s active pharmaceuticals ingredient (API) acetaminophen – recently celebrated its golden anniversary. On Nov. 16, 1966, Mallinckrodt Chemical Works dedicated what was its newest plant […] The post Mallinckrodt’s Raleigh Plant Marks 50th Anniversary appeared first on Mallinckrodt Pharmaceuticals Blog.

  • Mallinckrodt Celebrates Opening of New Research and Development Facility in Dublin, Ireland

    On September 19, 2016, Mallinckrodt celebrated the official opening of its new offices in Dublin, Ireland and announced the creation of a new €10 million state-of-the-art Research and Development (R&D) facility at the location. The […] The post Mallinckrodt Celebrates Opening of New Research and Development Facility in Dublin, Ireland appeared first on Mallinckrodt Pharmaceuticals Blog.

  • Mark Trudeau Speaks Out on Saving Future Generations from Prescription Drug Abuse

    As a company focused on our patients and communities, Mallinckrodt has long been a strong advocate of addressing the complex issues of opioid misuse and abuse. The company is committed to working collaboratively with a […] The post Mark Trudeau Speaks Out on Saving Future Generations from Prescription Drug Abuse appeared first on Mallinckrodt Pharmaceuticals Blog.

  • Mallinckrodt Scientists On Capitol Hill to Advocate for Biopharmaceutical Innovation

    The science of hope. The promise of innovation. This was the message heard throughout Capitol Hill during the Pharmaceutical Research and Manufacturers of America’s (PhRMA) first congressional “fly-in” focused specifically on the merits of drug […] The post Mallinckrodt Scientists On Capitol Hill to Advocate for Biopharmaceutical Innovation appeared first on Mallinckrodt Pharmaceuticals Blog.

Mallinckrodt Pharmaceuticals

Category: Content
Type: Blog Article

Generated 6 months ago

New blog articles detected

Out-Market Your Competitors?

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account Log in

Out-Market Your Competitors

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account

Already a user?  Log in